Helicobacter pylori and extragastric diseases

Current Topics in Microbiology and Immunology

Volumn 400, Issue , 2017, Pages 325-347

  Kyburz, Andreas ^a   Müller, Anne ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC DISEASE; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAUSAL ATTRIBUTION; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; EXTRAGASTRIC DISEASE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATORY BOWEL DISEASE; NONHUMAN; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; CROSS PROTECTION; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; MOUSE; PHYSIOLOGY;

ANIMALS; ASTHMA; CROSS PROTECTION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERSENSITIVITY; INFLAMMATORY BOWEL DISEASES; MICE;

EID: 85010908361     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-50520-6_14     Document Type: Chapter

References (109)

1. Ahmed N, Sechi LA (2005) Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann Clin Microbiol Antimicrobials 4:1. doi:10.1186/1476-0711-4-1
2. Amberbir A, Medhin G, Erku W, Alem A, Simms R, Robinson K, Fogarty A, Britton J, Venn A, Davey G (2011) Effects of Helicobacter pylori, geohelminth infection and selected commensal bacteria on the risk of allergic disease and sensitization in 3-year-old Ethiopian children. Clin Exp Allergy. doi:10.1111/j.1365-2222.2011.03831.x
3. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Müller A (2011a) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 121:3088-3093. doi:45041 [pii] 10.1172/JCI45041
4. Arnold IC, Hitzler I, Engler D, Oertli M, Agger EM, Müller A (2011b) The C-Terminally Encoded, MHC Class II-Restricted T Cell Antigenicity of the Helicobacter pylori Virulence Factor CagA Promotes Gastric Preneoplasia. J Immunol 186(11):6165-6172. doi:jimmunol.1003472 [pii] 10.4049/jimmunol.1003472
5. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Müller A (2011c) Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 140(1):199-209. doi:S0016-5085(10)00956-X [pii] 10.1053/j.gastro.2010. 06.047
6. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347(12):911-920. doi:10.1056/NEJMra020100347/12/911 [pii]
7. Backert S, Blaser MJ (2016) The role of CagA in the gastric biology of Helicobacter pylori. Cancer Res 76(14):4028-4031. doi:10.1158/0008-5472.CAN-16-1680
8. Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D’Haens G, Dotan I, Goh KL, Hibi T, Kozarek RA, Quigley EM, Reinisch W, Sands BE, Sollano JD, Steinhart AH, Steinwurz F, Vatn MH, Yamamoto-Furusho JK (2011) IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010—inflammatory bowel disease task force meeting. Inflamm Bowel Dis 17(2):639-644. doi:10.1002/ibd.21409
9. Blaser MJ, Chen Y, Reibman J (2008) Does Helicobacter pylori protect against asthma and allergy? Gut 57(5):561-567
10. Blaser MJ, Falkow S (2009) What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7(12):887-894. doi:nrmicro2245 [pii] 10.1038/nrmicro2245
11. Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100(16):1184-1187. doi:10.1093/jnci/djn211
12. Carroll IM, Khan AA, Ahmed N (2004) Revisiting the pestilence of Helicobacter pylori: insights into geographical genomics and pathogen evolution. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 4(2):81-90. doi:10.1016/j.meegid.2004.01.006
13. Castano-Rodriguez N, Kaakoush NO, Lee WS, Mitchell HM (2015) Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. doi:gutjnl-2015-310545 [pii] 10.1136/gutjnl-2015-310545
14. Chen Y, Blaser MJ (2007) Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 167(8):821-827
15. Chen Y, Blaser MJ (2008) Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 198(4):553-560
16. Chourasia D, Ghoshal UC (2008) Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play? Trop Gastroenterol: Official J Dig Dis Found 29(1):13-19
17. Chung SJ, Lim SH, Choi J, Kim D, Kim YS, Park MJ, Yim JY, Kim JS, Cho SH, Jung HC, Song IS (2011) Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched case-control study of 5616 health check-up Koreans. J Neurogastroenterol Motil 17(3):267-273. doi:10.5056/jnm.2011.17.3.267
18. Collen MJ, Johnson DA, Sheridan MJ (1994) Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci 39(2):410-417
19. Cook KW, Crooks J, Hussain K, O’Brien K, Braitch M, Kareem H, Constantinescu CS, Robinson K, Gran B (2015) Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front Microbiol 6:52. doi:10.3389/fmicb.2015.00052
20. Cover TL, Blaser MJ (2009) Helicobacter pylori in health and disease. Gastroenterology 136(6):1863-1873. doi:S0016-5085(09)00339-4 [pii] 10.1053/j.gastro.2009.01.073
21. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Camilleri M (2003) Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 18(3):279-289
22. Eder W, Ege MJ, von Mutius E (2006) The asthma epidemic. N Engl J Med 355(21):2226-2235
23. el-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, McColl KE (1994) Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 35(10):1385-1388
24. Engler DB, Leonardi I, Hartung ML, Kyburz A, Spath S, Becher B, Rogler G, Muller A (2015) Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18. Inflamm Bowel Dis 21(4):854-861. doi:10.1097/MIB.0000000000000318
25. Engler DB, Reuter S, van Wijck Y, Urban S, Kyburz A, Maxeiner J, Martin H, Yogev N, Waisman A, Gerhard M, Cover TL, Taube C, Muller A (2014) Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc Natl Acad Sci U S A 111 (32):11810-11815. doi:1410579111 [pii] 10.1073/pnas.1410579111
26. Fallone CA, Barkun AN, Friedman G, Mayrand S, Loo V, Beech R, Best L, Joseph L (2000) Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 95(4):914-920. doi:10.1111/j.1572-0241.2000.01929.x
27. Fischbach LA, Graham DY, Kramer JR, Rugge M, Verstovsek G, Parente P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Kolpachi A, Gupta S, Vela MF, Velez M, Cole R, Anand B, El Serag HB (2014) Association between Helicobacter pylori and Barrett’s esophagus: a case-control study. Am J Gastroenterol 109(3):357-368. doi:10.1038/ajg.2013.443
28. Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, El-Serag HB (2012) The association between Barrett’s esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 17(3):163-175. doi:10.1111/j.1523-5378.2011.00931.x
29. Forman D (2005) Re: the role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97(13):1013-1014; author reply 1014. doi:97/13/1013 [pii] 10.1093/jnci/dji180
30. Gall A, Fero J, McCoy C, Claywell BC, Sanchez CA, Blount PL, Li X, Vaughan TL, Matsen FA, Reid BJ, Salama NR (2015) Bacterial composition of the human upper gastrointestinal tract microbiome is dynamic and associated with genomic instability in a Barrett’s esophagus cohort. PLoS ONE 10(6):e0129055. doi:10.1371/journal.pone.0129055
31. Gardner JD, Sloan S, Robinson M, Miner PB Jr (2004) Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Aliment Pharmacol Ther 20(11-12):1381-1386. doi:10.1111/j.1365-2036.2004.02279.x
32. Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A (2014) Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 13(1):3-10. doi:10.1016/j.autrev.2013.06.004
33. Ghoshal UC, Chourasia D (2010) Gastroesophageal reflux disease and Helicobacter pylori: whatmay be the relationship? J Neurogastroenterol Motil 16(3):243-250. doi:10.5056/jnm.2010.16.3.243
34. Halme L, Rautelin H, Leidenius M, Kosunen TU (1996) Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol 49(1):65-67
35. Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Pena A, Rollan A, Viviani P, Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE, Smith PD (2008) Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134(2):491-499. doi:S0016-5085(07)01996-8 [pii] 10.1053/j.gastro.2007.11.006
36. Haruma K (2004) Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 20(Suppl 8):40-44. doi:10.1111/j.1365-2036.2004.02228.x
37. Helmer KS, West SD, Vilela R, Chang L, Cui Y, Kone BC, Mercer DW (2004) Lipopolysaccharide-induced changes in rat gastric H/K-ATPase expression. Ann Surg 239(4):501-509
38. Herbarth O, Bauer M, Fritz GJ, Herbarth P, Rolle-Kampczyk U, Krumbiegel P, Richter M, Richter T (2007) Helicobacter pylori colonisation and eczema. J Epidemiol Community Health 61(7):638-640. doi:61/7/638 [pii] 10.1136/jech.2006.046706
39. Herrera V, Parsonnet J (2009) Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 15(11):971-976. doi:CLM3031 [pii] 10.1111/j.1469-0691.2009.03031.x
40. Higgins PD, Johnson LA, Luther J, Zhang M, Sauder KL, Blanco LP, Kao JY (2010) Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: Mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis. doi:10.1002/ibd.21489
41. Hitzler I, Sayi A, Kohler E, Engler DB, Koch KN, Hardt WD, Muller A (2012) Caspase-1 Has Both Proinflammatory and Regulatory Properties in Helicobacter Infections, Which Are Differentially Mediated by Its Substrates IL-1beta and IL-18. J Immunol 188(8):3594-3602. doi:jimmunol.1103212 [pii] 10.4049/jimmunol.1103212
42. Iijima K, Koike T, Shimosegawa T (2015) Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol 6:566. doi:10.3389/fmicb.2015.00566
43. Jin X, Chen YP, Chen SH, Xiang Z (2013) Association between Helicobacter pylori infection and ulcerative colitis-a case control study from China. Int J Med Sci 10(11):1479-1484. doi:10.7150/ijms.6934ijmsv10p1479 [pii]
44. Kamada T, Haruma K, Kawaguchi H, Yoshihara M, Sumii K, Kajiyama G (1998) The association between antral G and D cells and mucosal inflammation, atrophy, and Helicobacter pylori infection in subjects with normal mucosa, chronic gastritis, and duodenal ulcer. Am J Gastroenterol 93(5):748-752. doi:10.1111/j.1572-0241.1998.218_a.x
45. Kandulski A, Malfertheiner P (2014) Helicobacter pylori and gastroesophageal reflux disease. Curr Opin Gastroenterol 30(4):402-407. doi:10.1097/MOG.0000000000000085
46. Kim DJ, Park JH, Franchi L, Backert S, Nunez G (2013) The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1beta production in Helicobacter pylori-infected dendritic cells. Eur J Immunol 43:2650-2658. doi:10.1002/eji.201243281
47. Koch KN, Hartung ML, Urban S, Kyburz A, Bahlmann AS, Lind J, Backert S, Taube C, Muller A (2015) Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J Clin Invest 125(8):3297-3302. doi:79337 [pii] 10.1172/JCI79337
48. Koch KN, Muller A (2015) Helicobacter pylori activates the TLR2/NLRP3/caspase-1/IL-18 axis to induce regulatory T-cells, establish persistent infection and promote tolerance to allergens. Gut Microbes 6(6):382-387. doi:10.1080/19490976.2015.1105427
49. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112(5):1442-1447
50. Laine L, Sugg J (2002) Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 97(12):2992-2997. doi:10.1111/j.1572-0241.2002.07116.x
51. Lao-Sirieix P, Corovic A, Jankowski J, Lowe A, Triadafilopoulos G, Fitzgerald RC (2008) Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus. Dis Esophagus: Official J Int Soc Dis Esophagus/ISDE 21(6):529-538. doi:10.1111/j.1442-2050.2007.00807.x
52. Lebwohl B, Blaser MJ, Ludvigsson JF, Green PH, Rundle A, Sonnenberg A, Genta RM (2013) Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol 178(12):1721-1730. doi:kwt234 [pii] 10.1093/aje/kwt234
53. Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, Wu MS, Lin JT (2013) The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 62(5):676-682. doi:10.1136/gutjnl-2012-302240
54. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, Achtman M (2007) An African origin for the intimate association between humans and Helicobacter pylori. Nature 445(7130):915-918. doi:nature05562 [pii] 10.1038/nature05562
55. Liu FX, Wang WH, Wang J, Li J, Gao PP (2011) Effect of Helicobacter pylori infection on Barrett’s esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux. Helicobacter 16(1):66-77. doi:10.1111/j.1523-5378.2010.00811.x
56. Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala AV, Paul JA, Kao JY (2011) Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut 60(11):1479-1486. doi:gut.2010.220087 [pii] 10.1136/gut.2010. 220087
57. Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474(7351):298-306. doi:10.1038/nature10208
58. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390):1311-1315
59. Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, Fujishiro M, Sakaguchi Y, Nakayama C, Konno-Shimizu M, Matsuda R, Mochizuki S, Asada-Hirayama I, Tsuji Y, Kodashima S, Ono S, Niimi K, Mitsushima T, Koike K (2013) Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS ONE 8(7):e69891. doi:10.1371/journal.pone.0069891
60. Nakajima S, Hattori T (2003) Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy. Helicobacter 8(4):279-293
61. Nie S, Chen T, Yang X, Huai P, Lu M (2014) Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus: Official J Int Soc Dis Esophagus/ISDE 27(7):645-653. doi:10.1111/dote.12194
62. Nordenstedt H, Nilsson M, Johnsen R, Lagergren J, Hveem K (2007) Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study). Helicobacter 12(1):16-22. doi:10.1111/j.1523-5378.2007.00466.x
63. Oertli M, Noben M, Engler DB, Semper RP, Reuter S, Maxeiner J, Gerhard M, Taube C, Muller A (2013) Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc Natl Acad Sci U S A 110(8):3047-3052. doi:1211248110 [pii] 10.1073/pnas.1211248110
64. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Jarbrink M, Muller A (2012) DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 122(3):1082-1096. doi:61029 [pii] 10.1172/JCI61029
65. Owyang SY, Luther J, Owyang CC, Zhang M, Kao JY (2012) Helicobacter pylori DNA’s anti-inflammatory effect on experimental colitis. Gut Microbes 3(2):168-171. doi:19181 [pii] 10.4161/gmic.19181
66. Parente F, Molteni P, Bollani S, Maconi G, Vago L, Duca PG, Rembacken B, Axon AT, Bianchi Porro G (1997) Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Scand J Gastroenterol 32(11):1140-1146
67. Parsonnet J, Friedman GD, Orentreich N, Vogelman H (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40(3):297-301
68. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325(16):1127-1131
69. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330(18):1267-1271
70. Parsonnet J, Isaacson PG (2004) Bacterial infection and MALT lymphoma. N Engl J Med 350(3):213-215
71. Pearce CB, Duncan HD, Timmis L, Green JR (2000) Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 12(4):439-443
72. Piodi LP, Bardella M, Rocchia C, Cesana BM, Baldassarri A, Quatrini M (2003) Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J Clin Gastroenterol 36(1):22-25
73. Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97(2):142-146. doi:97/2/142 [pii] 10.1093/jnci/dji024
74. Pritchard DM, Crabtree JE (2006) Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol 22(6):620-625. doi:10.1097/01.mog.0000245539.50765.f600001574-200611000-00007 [pii]
75. Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z (2004) Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease—antibiotic use in the history does not play a significant role. Helicobacter 9(3):278-283. doi:10.1111/j.1083-4389.2004.00223.xHEL223 [pii]
76. Qian B, Ma S, Shang L, Qian J, Zhang G (2011) Effects of Helicobacter pylori eradication on gastroesophageal reflux disease. Helicobacter 16(4):255-265. doi:10.1111/j.1523-5378.2011.00846.x
77. Rad R, Ballhorn W, Voland P, Eisenacher K, Mages J, Rad L, Ferstl R, Lang R, Wagner H, Schmid RM, Bauer S, Prinz C, Kirschning CJ, Krug A (2009) Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 136(7):2247-2257. doi:S0016-5085(09)00352-7 [pii] 10.1053/j.gastro. 2009.02.066
78. Raghunath A, Hungin AP, Wooff D, Childs S (2003) Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326(7392):737. doi:10.1136/bmj.326.7392.737
79. Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, Blaser MJ (2008) Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS ONE 3(12):e4060
80. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Polson RJ, Zaitoun AM, Atherton JC (2008) Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 57(10):1375-1385. doi:gut.2007.137539 [pii] 10.1136/gut. 2007.137539
81. Roka K, Roubani A, Stefanaki K, Panayotou I, Roma E, Chouliaras G (2014) The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease. Helicobacter 19(5):400-405. doi:10.1111/hel.12141
82. Rokkas T, Gisbert JP, Niv Y, O’Morain C (2015) The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United European Gastroenterol J 3(6):539-550. doi:10.1177/205064061558088910.1177_2050640615580889 [pii]
83. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G (2007) Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 5(12):1413-1417, 1417 e1411-1412. doi:10.1016/j.cgh.2007.08.010
84. Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, Metko V, Kao JY (2014) Association between Helicobacter pylori and Barrett’s esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 12(2):239-245. doi:10.1016/j.cgh.2013.08.029
85. Runge TM, Abrams JA, Shaheen NJ (2015) Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 44(2):203-231. doi:10.1016/j.gtc.2015.02.001
86. Saad AM, Choudhary A, Bechtold ML (2012) Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol 47(2):129-135. doi:10.3109/00365521.2011.648955
87. Sakata H, Fujimoto K (2005) Barrett’s esophagus and Helicobacter pylori. Nihon Rinsho 63(8):1383-1386
88. Salama NR, Hartung ML, Muller A (2013) Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol 11(6):385-399. doi:nrmicro3016 [pii] 10.1038/nrmicro3016
89. Sayi A, Kohler E, Toller IM, Flavell RA, Muller W, Roers A, Müller A (2011) TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 186(2):878-890. doi:jimmunol.1002269 [pii] 10.4049/jimmunol. 1002269
90. Semper RP, Mejias-Luque R, Gross C, Anderl F, Muller A, Vieth M, Busch DH, Prazeres da Costa C, Ruland J, Gross O, Gerhard M (2014) Helicobacter pylori-Induced IL-1beta Secretion in Innate Immune Cells Is Regulated by the NLRP3 Inflammasome and Requires the Cag Pathogenicity Island. J Immunol 193:3566-3576. doi:jimmunol.1400362 [pii] 10.4049/ jimmunol.1400362
91. Serrano C, Wright SW, Bimczok D, Shaffer CL, Cover TL, Venegas A, Salazar MG, Smythies LE, Harris PR, Smith PD (2013) Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori-infected children. Mucosal Immunol 6(5):950-959. doi:mi2012133 [pii] 10.1038/mi.2012.133
92. Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 287(15):1972-1981
93. Shiotani A, Miyanishi T, Kamada T, Haruma K (2008) Helicobacter pylori infection and allergic diseases: epidemiological study in Japanese university students. J Gastroenterol Hepatol 23(7 Pt 2):e29-33. doi:JGH5107 [pii] 10.1111/j.1440-1746.2007.05107.x
94. Sonnenberg A, Genta RM (2012) Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther 35(4):469-476. doi:10.1111/j.1365-2036.2011.04969.x
95. Sonnenberg A, Genta RM (2016) Inverse Association Between Helicobacter pylori Gastritis and Microscopic Colitis. Inflamm Bowel Dis 22(1):182-186. doi:10.1097/MIB.0000000000000595
96. Sun X, Zhang M, El-Zataari M, Owyang SY, Eaton KA, Liu M, Chang YM, Zou W, Kao JY (2013) TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PLoS ONE 8(9):e74595. doi:10.1371/journal.pone.0074595PONE-D-13-08235 [pii]
97. Tanaka I, Tatsumi Y, Kodama T, Kato K, Fujita S, Mitsufuji S, Kashima K (2004) Effect of Helicobacter pylori eradication on gastroesophageal function. J Gastroenterol Hepatol 19(3):251-257
98. Thrift AP, Pandeya N, Smith KJ, Green AC, Hayward NK, Webb PM, Whiteman DC (2012) Helicobacter pylori infection and the risks of Barrett’s oesophagus: a population-based case-control study. Int J Cancer 130(10):2407-2416. doi:10.1002/ijc.26242
99. Tsuji K, Uehara A, Okumura T, Taniguchi Y, Kitamori S, Takasugi Y, Namiki M (1992) The gastric antisecretory action of lipopolysaccharide is blocked by indomethacin. Eur J Pharmacol 210(2):213-215
100. Vaira D, Vakil N, Rugge M, Gatta L, Ricci C, Menegatti M, Leandro G, Holton J, Russo VM, Miglioli M (2003) Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects. Gut 52(11):1543-1547
101. Wang F, Xia P, Wu F, Wang D, Wang W, Ward T, Liu Y, Aikhionbare F, Guo Z, Powell M, Liu B, Bi F, Shaw A, Zhu Z, Elmoselhi A, Fan D, Cover TL, Ding X, Yao X (2008) Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem 283(39):26714-26725. doi:10.1074/jbc.M800527200
102. Wang Q, Yu C, Sun Y (2013) The association between asthma and Helicobacter pylori: a meta-analysis. Helicobacter 18(1):41-53. doi:10.1111/hel.12012
103. Weyermann M, Rothenbacher D, Brenner H (2009) Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol 104(1):182-189. doi:ajg200861 [pii] 10.1038/ajg.2008.61
104. Wu XW, Ji HZ, Yang MF, Wu L, Wang FY (2015) Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol 21(15): 4750-4756. doi:10.3748/wjg.v21.i15.4750
105. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427-434. doi:10.1038/nature06005
106. Xie FJ, Zhang YP, Zheng QQ, Jin HC, Wang FL, Chen M, Shao L, Zou DH, Yu XM, Mao WM (2013a) Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J Gastroenterol 19(36):6098-6107. doi:10.3748/wjg.v19.i36.6098
107. Xie T, Cui X, Zheng H, Chen D, He L, Jiang B (2013b) Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 25(10):1195-1205. doi:10.1097/MEG.0b013e328363e2c7
108. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH (2010) Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 105(5):1007-1013; quiz 1006, 1014. doi:10.1038/ajg.2009.734
109. Zhou X, Wu J, Zhang G (2013) Association between Helicobacter pylori and asthma: a meta-analysis. Eur J Gastroenterol Hepatol 25(4):460-468. doi:10.1097/MEG.0b013e32835c280a